These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20471127)

  • 1. Functional intestinal microbiome, new frontiers in prebiotic design.
    Candela M; Maccaferri S; Turroni S; Carnevali P; Brigidi P
    Int J Food Microbiol; 2010 Jun; 140(2-3):93-101. PubMed ID: 20471127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The developing intestinal microbiome and its relationship to health and disease in the neonate.
    Murgas Torrazza R; Neu J
    J Perinatol; 2011 Apr; 31 Suppl 1():S29-34. PubMed ID: 21448201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the development of the intestinal microbiota in infancy.
    Vael C; Desager K
    Curr Opin Pediatr; 2009 Dec; 21(6):794-800. PubMed ID: 19770768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation method for screening of candidate prebiotic foods.
    Date Y; Nakanishi Y; Fukuda S; Nuijima Y; Kato T; Umehara M; Ohno H; Kikuchi J
    Food Chem; 2014; 152():251-60. PubMed ID: 24444934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta'omic analytic techniques for studying the intestinal microbiome.
    Morgan XC; Huttenhower C
    Gastroenterology; 2014 May; 146(6):1437-1448.e1. PubMed ID: 24486053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing future prebiotic fiber to target metabolic syndrome.
    Jakobsdottir G; Nyman M; Fåk F
    Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition, intestinal defence and the microbiome.
    Kelly P
    Proc Nutr Soc; 2010 May; 69(2):261-8. PubMed ID: 20202280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota and overweight.
    Lyra A; Lahtinen S; Tiihonen K; Ouwehand AC
    Benef Microbes; 2010 Nov; 1(4):407-21. PubMed ID: 21831779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals.
    Possemiers S; Bolca S; Verstraete W; Heyerick A
    Fitoterapia; 2011 Jan; 82(1):53-66. PubMed ID: 20655994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disease and metagenomics of intestinal microbiomes].
    Hattori M
    Nihon Rinsho; 2009 Jun; 67(6):1214-8. PubMed ID: 19507517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune disease in the era of the metagenome.
    Proal AD; Albert PJ; Marshall T
    Autoimmun Rev; 2009 Jul; 8(8):677-81. PubMed ID: 19393196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics view on gut microbiome modulation by polyphenol-rich foods.
    Moco S; Martin FP; Rezzi S
    J Proteome Res; 2012 Oct; 11(10):4781-90. PubMed ID: 22905879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotics and calcium bioavailability.
    Cashman K
    Curr Issues Intest Microbiol; 2003 Mar; 4(1):21-32. PubMed ID: 12691259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
    Cani PD; Delzenne NM
    Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity.
    Martin FP; Wang Y; Yap IK; Sprenger N; Lindon JC; Rezzi S; Kochhar S; Holmes E; Nicholson JK
    J Proteome Res; 2009 Jul; 8(7):3464-74. PubMed ID: 19492798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fibres as "prebiotics": implications for colorectal cancer.
    Lim CC; Ferguson LR; Tannock GW
    Mol Nutr Food Res; 2005 Jun; 49(6):609-19. PubMed ID: 15864790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metagenomic insight into our gut's microbiome.
    Lepage P; Leclerc MC; Joossens M; Mondot S; Blottière HM; Raes J; Ehrlich D; Doré J
    Gut; 2013 Jan; 62(1):146-58. PubMed ID: 22525886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the intestinal microbiota in the pediatric population: a clinical perspective.
    Ringel-Kulka T
    Nutr Clin Pract; 2012 Apr; 27(2):226-34. PubMed ID: 22402406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-accessible pectic poly- and oligosaccharides in gut health.
    Tingirikari JMR
    Food Funct; 2018 Oct; 9(10):5059-5073. PubMed ID: 30280147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
    Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
    Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.